GRAIL Cash Flow Statement
NASDAQ: GRALHealth CareMedical SpecialitiesUSD
140.58+7.97 (+6.01%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
GRAIL free cash flow
In fiscal 2025, GRAIL generated -$299.0 million of operating cash flow and spent $909,000 on capital expenditures. That left free cash flow of -$299.9 million, a free-cash-flow margin of -203.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
GRAIL cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20232023-01-01 |
|---|---|---|---|---|
| Net Income | -408.35M | -2.03B | -1.47B | -5.40B |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 18.01M | 19.72M | 20.36M | 16.43M |
| Stock-Based Compensation | 58.28M | 86.08M | 97.23M | 75.73M |
| Change in Working Capital | -1.05M | -18.00M | 1.51M | -6.34M |
| Operating Cash Flow | -299.01M | -577.16M | -595.80M | -561.31M |
| Capital Expenditures | -909.00K | -5.21M | -12.89M | -22.86M |
| Investing Cash Flow | -85.05M | -551.01M | -12.89M | -22.86M |
| Financing Cash Flow | 423.32M | 1.24B | 463.77M | 604.82M |
| Net Change in Cash | 39.12M | 116.07M | -144.62M | 20.13M |
| Free Cash Flow | -299.92M | -582.36M | -608.69M | -584.17M |
This table shows 4 annual periods of GRAIL's cash flow statement, from FY 2025 back to FY 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GRAL's reporting calendar. What is a cash flow statement?